View in EDS

Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.

Saved in:
Bibliographic Details
Title: Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.
Authors: Bewersdorf JP; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Wang R; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut, USA., Mendez L; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Mina A; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Aguirre LE; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Stahl M; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Zeidan AM; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA., Ma X; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut, USA., Podoltsev NA; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
Source: Cancer [Cancer] 2026 May 01; Vol. 132 (9), pp. e70415.
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42033416
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bewersdorf+JP%22">Bewersdorf JP</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Wang+R%22">Wang R</searchLink>; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mendez+L%22">Mendez L</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Mina+A%22">Mina A</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Aguirre+LE%22">Aguirre LE</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Stahl+M%22">Stahl M</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Zeidan+AM%22">Zeidan AM</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Ma+X%22">Ma X</searchLink>; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.; Yale Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Podoltsev+NA%22">Podoltsev NA</searchLink>; Section of Medical Oncology and Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.; Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2026 May 01; Vol. 132 (9), pp. e70415.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42033416
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.70415
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70415
    Titles:
      – TitleFull: Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bewersdorf JP
      – PersonEntity:
          Name:
            NameFull: Wang R
      – PersonEntity:
          Name:
            NameFull: Mendez L
      – PersonEntity:
          Name:
            NameFull: Mina A
      – PersonEntity:
          Name:
            NameFull: Aguirre LE
      – PersonEntity:
          Name:
            NameFull: Stahl M
      – PersonEntity:
          Name:
            NameFull: Zeidan AM
      – PersonEntity:
          Name:
            NameFull: Ma X
      – PersonEntity:
          Name:
            NameFull: Podoltsev NA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 132
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1